Classer les publications sur l'année
-
Économie de la santé
Modelling lifetime cost consequences of toric compared with standard IOLs in cataract surgery of astigmatic patients in four European countries
LAURENDEAU C, LAFUMA A, BERDEAUX G
J Med Economics ; 12(3):230-237
-
Économie de la santé
Modelling the lifetime economic consequences of glaucoma in France
PHILIPPE NORDMANN J, LAFUMA A, BERDEAUX G
J Med Econ ; 12(1):9-16
-
Économie de la santé
Modelling lifetimes cost consequences of RESTOR for presbyopia in four European countries
LAFUMA A, BERDEAUX G
Eye ; 23(5):1072-80
-
Pharmaco-Epidémiologie
Les troubles musculosquelettiques en viticulture : prévalence et associations avec le travail de la vigne et les facteurs psychosociaux au travail
BERNARD C, BOUÉE S, COUROUVE L, ADJEMIAN A, CHRETIEN JC, NIEDHAMMER I
Arch Mal Prof Environ ; 70:539-549
-
Pharmaco-Epidémiologie
Incidence of Nd : YAG laser capsulotomies after cataract surgery : comparison of 3 square-edged lenses of different composition
BOUREAU C, LAFUMA A, JEANBAT V, BERDEAUX G, SMITH ANDREW F
Can J Ophtalmol ; 44(2):165-170
-
Économie de la santé
Economics and attitudes regarding spectacles in daily life : a European perspective
Economics and attitudes regarding spectacles in daily life : a European perspective
Ophthalmic Epidemiol ; 16(4):218-223
-
Économie de la santé
Cost of cataract surgery after implantation of three intraocular lenses
BOUREAU C, LAFUMA A, JEANBAT V, SMITH AF, BERDEAUX G
Clin Ophtalmol ; 3:277-285
-
Économie de la santé
Cost effectiveness of Travoprost versus a Fixed Combination of Latanoprost/Timolol in Patients with Ocular Hypertension or Glaucoma : Analysis Based on the UK General Practitioner Research DataBase
DE NATALE R, LAFUMA A, BERDEAUX G
Clin Drug Investig ; 29(2):111-120
-
Économie de la santé
Modelling lifetimes cost consequences of RESTOR in cataract surgery in four European countries
LAFUMA A, BERDEAUX G
BMC Ophtalmol ; 8(1):12
-
Pharmaco-Epidémiologie
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study
DENIS P, LAFUMA A, JEANBAT V, LAURENDEAU C, BERDEAUX G
Clin Drug Investig ; 28(12):767-776
-
Pharmaco-Epidémiologie
Intermediate visual acuity without spectacles following bilateral ReSTOR® implantation
CUQ C, SPERA C, LAURENDEAU C, LAFUMA A, BERDEAUX G
Eur J Ophtalmol ; 18(5):733-738
-
Économie de la santé
Costs and persistence of carbonic anhydrase inhibitor versus alpha2 agonists, associated with beta-blockers, in glaucoma an ocular hypertension : an analysis of the UKGPRD database
LAFUMA A, BERDEAUX G
Curr Med Res Opin ; 24(5):1519-1527
-
Économie de la santé
Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care : an analysis conducted on the UK General Practitioner Research Database
LAFUMA A, LAURENDEAU C, BERDEAUX G
J Med Econ ; 11(3):485-497
-
Économie de la santé
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by the United Kingdom General Practitioner Research Database
DENIS P, LAFUMA A, BERDEAUX G
Clin Ophtalmol ; 2(2):321-329
-
Pharmaco-Epidémiologie
A european survey of patient satisfaction with spectacles after cataract surgery and the associated costs in four European countries (France, Germany, Spain and Italy)
CUQ C, LAFUMA A, JEANBAT V, BERDEAUX G
Ophthalmic Epidemiol ; 15:234-241